Anti-ITM2B antibody,Abcam,AB101522

Host

Rabbit

Reactivity

Rat, Human, Mouse

Application

ICC/IF, WB

Platform ID

BAB985783592

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Abcam

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Email:

[email protected]

Product Specifications
Scientific Background

Specifications

NameAnti-ITM2B antibody
Cat. No.AB101522
HostRabbit
IsotypeIgG
ReactivityRat, Human, Mouse
ApplicationICC/IF, WB
ClonalityPolyclonal
Concentration0.67 mg/mL Batch dependent concentration
ImmunogenRecombinant Fragment Protein within Human ITM2B aa 50-250. The exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Immunogen
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7 Preservative: 0.025% Proclin 300 Constituents: PBS, 20% Glycerol (glycerin, glycerine)
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Plays a regulatory role in the processing of the amyloid-beta A4 precursor protein (APP) and acts as an inhibitor of the amyloid-beta peptide aggregation and fibrils deposition. Plays a role in the induction of neurite outgrowth. Functions as a protease inhibitor by blocking access of secretases to APP cleavage sites.. Mature BRI2 (mBRI2) functions as a modulator of the amyloid-beta A4 precursor protein (APP) processing leading to a strong reduction in the secretion of secretase-processed amyloid-beta protein 40 and amyloid-beta protein 42.. Bri23 peptide prevents aggregation of APP amyloid-beta protein 42 into toxic oligomers. See full target information ITM2B

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.